跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
皿治林 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Mizolastine Sustained Release Tablets
Approved
化学药品
Mizolastine Sustained Release Tablets
THERABEL HEALTHCARE LIMITED
🇨🇳 National Medical Products Administration
Approval Date
May 23, 2022
Approval ID
8J1seMW8k2V
Company
THERABEL HEALTHCARE LIMITED
Type
化学药品
Approval Details
Approval Id
8J1seMW8k2V
Approval Number
国药准字HJ20171170
Generic Name
咪唑斯汀缓释片
Generic Name En
Mizolastine Sustained Release Tablets
Trade Name
皿治林
Drug Type
化学药品
Dosage Form
片剂
Strength
10mg
Reg Date
2022-05-23
Expired Date
2027-05-22
Company Name
THERABEL HEALTHCARE LIMITED
Production Company Name
SANOFI WINTHROP INDUSTRIE
Company Detail Path
/organization/therabel-healthcare-limited
Production Company Detail Path
/organization/sanofi-winthrop-industrie
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
May 23, 2022
Approval ID
8J1seMW8k2V
Type
化学药品
Back to NMPA Approvals